{"nct_id":"NCT05092360","title":"Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)","status":"TERMINATED","status_verified_date":"2025-06","start_date":"2022-01-10","start_date_type":"ACTUAL","primary_completion_date":"2025-01-08","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MURA"]}